Safety Study of GPX-150 in Patients With Solid Tumors

NCT00710125 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors - Phase 1 Population

Interventions

DRUG: GPX-150 for Injection

Sponsor

Gem Pharmaceuticals